6 Results for "

irisin

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "irisin" in MCE Product Catalog:

14
14 Publications Verification
Cat. No.: HY-P70664
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: FNDC5; Fibronectin Type III Domain-Containing Protein 5; Fibronectin Type III Domain Containing 5; Fibronectin Type III Repeat-Containing Protein 2; FRCP2; irisin
Species:  
Human Rat Mouse
Source:  
HEK293
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P70665
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: FNDC5; Fibronectin Type III Domain-Containing Protein 5; Fibronectin Type III Domain Containing 5; Fibronectin Type III Repeat-Containing Protein 2; FRCP2; irisin
Species:  
Rat Mouse Human
Source:  
HEK293
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P72534
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: FNDC5; Fibronectin Type III Domain-Containing Protein 5; Fibronectin Type III Domain Containing 5; Fibronectin Type III Repeat-Containing Protein 2; FRCP2; irisin
Species:  
Human Rat Mouse
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-N8445
CAS No.: 15592-37-7
Glucoerucin potassium is an orally active PTP1B non-competitive allosteric inhibitor (IC50 = 6.07 μM) and H2S donor that can be isolated and extracted from Eruca sativa. Glucoerucin potassium upregulates the Nrf2 pathway and promotes irisin/UCP1-mediated adipose tissue browning through conversion to erucin or acting as a sustained-release H2S donor, thereby regulating metabolic and cardiovascular functions. Glucoerucin potassium also exerts anticancer effects by upregulating epoxide hydrolase and through non-competitive allosteric inhibition of PTP1B. Glucoerucin potassium can be used in research on obesity, cancer, type 2 diabetes, and cardiovascular and cerebrovascular diseases .
loading...
    loading...
Cat. No.: HY-N9924
CAS No.: 21973-56-8
Glucoerucin potassium is an orally active PTP1B non-competitive allosteric inhibitor (IC50 = 6.07 μM) and H2S donor that can be isolated and extracted from Eruca sativa. Glucoerucin potassium upregulates the Nrf2 pathway and promotes irisin/UCP1-mediated adipose tissue browning through conversion to erucin or acting as a sustained-release H2S donor, thereby regulating metabolic and cardiovascular functions. Glucoerucin potassium also exerts anticancer effects by upregulating epoxide hydrolase and through non-competitive allosteric inhibition of PTP1B. Glucoerucin potassium can be used in research on obesity, cancer, type 2 diabetes, and cardiovascular and cerebrovascular diseases .
loading...
    loading...
Cat. No.: HY-RS05022
Research Areas:  

Others

FNDC5 Human Pre-designed siRNA Set A contains three designed siRNAs for FNDC5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...